Search research articles
Contact Us
Filters
Showing results (61-70 of 151) with videos related to
Page
of 16
Sort By:
Clinical Sarcoma Research
|
September 18, 2020
Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study
Arie Jan Verschoor, Saskia Litière, Sandrine Marréaud, et al.
Clinical Sarcoma Research
|
February 10, 2015
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
Marco Maruzzo, Juan Martin-Liberal, Christina Messiou, et al.
British Journal of Cancer
|
February 1, 2017
The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities
Jonathan Noujaim, Robin L Jones, John Swansbury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2009
Prospective validation of a prognostic score to improve patient selection for oncology phase I trials
Hendrik-Tobias Arkenau, Jorge Barriuso, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2008
Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital
Vasilios Karavasilis, Laurence Digue, Tobias Arkenau, et al.
American Journal of Clinical Oncology
|
November 3, 2015
Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma
Jonathan Noujaim, Anastasia Constantinidou, Christina Messiou, et al.
Expert Review of Anticancer Therapy
|
November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
Christopher P Wilding, Mark L Elms, Ian Judson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignancies
Charlotte Rees, P Beale, Jose Manuel Trigo, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005)
Anne O'Donnell, Cornelis J A Punt, Ian Judson, et al.
British Journal of Cancer
|
June 5, 2024
Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines
Ian Judson, Robin L Jones, Newton A C S Wong, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 151) with videos related to
Sort By:
Page
of 16
Clinical Sarcoma Research
|
September 18, 2020
Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study
Arie Jan Verschoor, Saskia Litière, Sandrine Marréaud, et al.
Clinical Sarcoma Research
|
February 10, 2015
Pazopanib as first line treatment for solitary fibrous tumours: the Royal Marsden Hospital experience
Marco Maruzzo, Juan Martin-Liberal, Christina Messiou, et al.
British Journal of Cancer
|
February 1, 2017
The spectrum of EWSR1-rearranged neoplasms at a tertiary sarcoma centre; assessing 772 tumour specimens and the value of current ancillary molecular diagnostic modalities
Jonathan Noujaim, Robin L Jones, John Swansbury, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 2009
Prospective validation of a prognostic score to improve patient selection for oncology phase I trials
Hendrik-Tobias Arkenau, Jorge Barriuso, David Olmos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2008
Identification of factors limiting patient recruitment into phase I trials: a study from the Royal Marsden Hospital
Vasilios Karavasilis, Laurence Digue, Tobias Arkenau, et al.
American Journal of Clinical Oncology
|
November 3, 2015
Successful Ifosfamide Rechallenge in Soft-Tissue Sarcoma
Jonathan Noujaim, Anastasia Constantinidou, Christina Messiou, et al.
Expert Review of Anticancer Therapy
|
November 1, 2019
The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib
Christopher P Wilding, Mark L Elms, Ian Judson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 11, 2003
Phase I trial of ZD9331, a nonpolyglutamatable thymidylate synthase inhibitor, given as a 5-day continuous infusion to patients with refractory solid malignancies
Charlotte Rees, P Beale, Jose Manuel Trigo, et al.
Cancer Chemotherapy and Pharmacology
|
December 24, 2002
A study to evaluate the pharmacokinetics of oral 5-fluorouracil and eniluracil after concurrent administration to patients with refractory solid tumours and varying degrees of renal impairment (FUMA1005)
Anne O'Donnell, Cornelis J A Punt, Ian Judson, et al.
British Journal of Cancer
|
June 5, 2024
Gastrointestinal stromal tumour (GIST): British Sarcoma Group clinical practice guidelines
Ian Judson, Robin L Jones, Newton A C S Wong, et al.
Page
of 16